Related Experiment Videos
Clinical applications of stem cell transfusion from cord blood
E Gluckman1, D Thierry, S Lesage
1Bone Marrow Transplant Unit and Laboratory of Stem Cell Biology, Hôpital Saint Louis, Paris, France.
Transfusion Science
|December 10, 1991
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Outcomes, infections, and immune reconstitution after double cord blood transplantation in patients with high-risk hematological diseases.
Transplant infectious disease : an official journal of the Transplantation Society·2011
Mesenchymal stem cells improve small intestinal integrity through regulation of endogenous epithelial cell homeostasis.
Cell death and differentiation·2009
Selected Stro-1-enriched bone marrow stromal cells display a major suppressive effect on lymphocyte proliferation.
International journal of laboratory hematology·2009
Human mesenchymal stem cells home specifically to radiation-injured tissues in a non-obese diabetes/severe combined immunodeficiency mouse model.
The British journal of radiology·2007
Peripheral blood natural killer cell count is associated with clinical outcome in patients with aaIPI 2-3 diffuse large B-cell lymphoma.
Annals of oncology : official journal of the European Society for Medical Oncology·2007
Post-transfusion thrombocytopenia in recipients with anti-HLA antibody.
Transfusion science·2000
Regulation of intracellular iron levels in iron-acceptor and iron-donor cells.
Transfusion science·2000
Transfusional iron overload and chelation therapy with deferoxamine and deferiprone (L1).
Transfusion science·2000
Clinical aspects of hemochromatosis.
Transfusion science·2000
Serum Retinol-Binding Protein 4 Levels in Hypertensive and Normotensive Individuals.
Journal of the College of Physicians and Surgeons--Pakistan : JCPSP·2026
Hereditary angioedema in women: Hormonal and reproductive influences on disease activity.
Allergy and asthma proceedings·2026
Outcomes of patients with myelofibrosis treated with ruxolitinib and anemia-supporting medications.
Hematology (Amsterdam, Netherlands)·2026
Conditioning Intensity and Outcomes in Pediatric HLA-Identical Transplant for Sickle Cell Disease: Comparison of MAC, RIC, and NMA.
Transplantation and cellular therapy·2026